Germany
Japan
United Kingdom
China
Antibodies
View as table Download
FAIM2 / LIFEGUARD Rabbit Polyclonal (N-Terminus) Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | FAIM2 / LIFEGUARD antibody was raised against synthetic peptide from human FAIM2. |
Rabbit Polyclonal Anti-ARC Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human ARC |
TA349251 is a possible alternative to TA349500.
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-CYSLTR1 Antibody (C-Terminus)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | CYSLTR1 / CYSLT1 antibody was raised against synthetic 20 amino acid peptide from C-terminus of human CYSLTR1 / CYSLT1. Percent identity with other species by BLAST analysis: Human, Gorilla (100%); Monkey, Marmoset (95%); Gibbon, Mouse, Panda (90%); Rat, Bovine, Elephant, Rabbit, Pig (85%). |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit polyclonal TGFBR2 (Ab-250) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human TGFBR2 around the phosphorylation site of serine 250 (D-R-SP-D-I). |
Calneuron-1 / CALN1 Rabbit Polyclonal (N-Terminus) Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Calneuron-1 / CALN1 antibody was raised against a 16 amino acid peptide near the amino terminus of human CaBP8. |
Rabbit Polyclonal antibody to Ribosome binding protein 1 (ribosome binding protein 1 homolog 180kDa (dog))
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1183 and 1410 of Ribosome binding protein 1 (Uniprot ID#Q9P2E9) |
Rabbit Polyclonal DRAM Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | DRAM antibody was raised against a 16 amino acid synthetic peptide from near the amino terminus of human DRAM. The immunogen is located within amino acids 30 - 80 of DRAM. |
Rabbit Polyclonal antibody to VAPA (VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region within amino acids 29 and 122 of VAPA (Uniprot ID#Q9P0L0) |
TGFBI Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Dog, Gorilla, Horse, Human, Mouse, Pig, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | TGFBI antibody was raised against synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%); Marmoset, Platypus (92%). |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Active filters
Reactivities
- Mouse
Applications
- IHC
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Category
Target Symbol
- CLDN7 (4)
- SPAG4 (4)
- TRPC6 (4)
- ACVR1C (3)
- APLNR (3)
- AQP3 (3)
- CLDN5 (3)
- EIF2AK3 (3)
- FGFR2 (3)
- FZD8 (3)
- GJB6 (3)
- GRIK1 (3)
- GRIN1 (3)
- GRM3 (3)
- GRM4 (3)
- IGF2R (3)
- MME (3)
- NTRK1 (3)
- SCN11A (3)
- SLC22A17 (3)
- STEAP4 (3)
- TNFSF13 (3)
- TRPC3 (3)
- TRPM7 (3)
- VTCN1 (3)
- A4GNT (2)
- ABCB5 (2)
- ABCB6 (2)
- ABHD12 (2)
- ACE2 (2)
- ADAM2 (2)
- ADAM20 (2)
- ADAM7 (2)
- ADCY4 (2)
- ADCY5 (2)
- ADGRB1 (2)
- ADIPOR2 (2)
- ADRA1A (2)
- ADRB3 (2)
- ALDH6A1 (2)
- ALG12 (2)
- ALG9 (2)
- APLP1 (2)
- APOB (2)
- APP (2)
- AQP1 (2)
- AQP2 (2)
- AQP5 (2)
- AQP8 (2)
- ARMCX3 (2)
- ARSK (2)
- ATP1A1 (2)
- AUP1 (2)
- BAI2 (2)
- BAX (2)
- BDNF (2)
- BMPR2 (2)
- BNIP1 (2)
- BPIFB2 (2)
- CA4 (2)
- CADM4 (2)
- CAV3 (2)
- CCR3 (2)
- CD151 (2)
- CD44 (2)
- CD93 (2)
- CDH1 (2)
- CDH23 (2)
- CELSR2 (2)
- CFTR (2)
- CLDN1 (2)
- CLDN10 (2)
- CLDN19 (2)
- CLEC4C (2)
- CNGA1 (2)
- CNGA2 (2)
- CNNM3 (2)
- COX16 (2)
- COX4I1 (2)
- CSF1R (2)
- CSGALNACT2 (2)
- CYP2E1 (2)
- CYP3A4 (2)
- DIABLO (2)
- ECRG4 (2)
- EDA (2)
- EFNB1 (2)
- EGF (2)
- ENPP3 (2)
- EPHB6 (2)
- ERBB3 (2)
- FAM3A (2)
- FAT4 (2)
- FGFR3 (2)
- FPR2 (2)
- FZD3 (2)
- GABBR1 (2)
- GLRA1 (2)
- GRIA2 (2)
- GRIA3 (2)
Antibody Hosts
Modifications
Pathways
- Neuroactive ligand-receptor interaction (101)
- Cytokine-cytokine receptor interaction (75)
- Pathways in cancer (63)
- Metabolic pathways (54)
- Calcium signaling pathway (46)
- Cell adhesion molecules (CAMs) (43)
- Endocytosis (38)
- Alzheimer's disease (33)
- MAPK signaling pathway (33)
- Hematopoietic cell lineage (29)
- Axon guidance (27)
- Leukocyte transendothelial migration (26)
- Regulation of actin cytoskeleton (26)
- Colorectal cancer (25)
- Melanogenesis (25)
- Wnt signaling pathway (23)
- ABC transporters (21)
- Adherens junction (20)
- Jak-STAT signaling pathway (20)
- Focal adhesion (19)
- Chemokine signaling pathway (18)
- Tight junction (18)
- Basal cell carcinoma (17)
- Amyotrophic lateral sclerosis (ALS) (16)
- Dilated cardiomyopathy (16)
- TGF-beta signaling pathway (16)
- Huntington's disease (15)
- Vascular smooth muscle contraction (15)
- Gap junction (14)
- Toll-like receptor signaling pathway (14)
- Neurotrophin signaling pathway (13)
- Pancreatic cancer (13)
- Apoptosis (12)
- ECM-receptor interaction (12)
- Long-term potentiation (12)
- Hypertrophic cardiomyopathy (HCM) (11)
- SNARE interactions in vesicular transport (11)
- Adipocytokine signaling pathway (10)
- ErbB signaling pathway (10)
- Hedgehog signaling pathway (10)
- Melanoma (10)
- Natural killer cell mediated cytotoxicity (10)
- Prostate cancer (10)
- Purine metabolism (10)
- Renin-angiotensin system (10)
- Chronic myeloid leukemia (9)
- GnRH signaling pathway (9)
- Drug metabolism - cytochrome P450 (8)
- Oocyte meiosis (8)
- Parkinson's disease (8)
- Retinol metabolism (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Bladder cancer (7)
- Long-term depression (7)
- Metabolism of xenobiotics by cytochrome P450 (7)
- N-Glycan biosynthesis (7)
- Notch signaling pathway (7)
- PPAR signaling pathway (7)
- Pathogenic Escherichia coli infection (7)
- Progesterone-mediated oocyte maturation (7)
- Taste transduction (7)
- Thyroid cancer (7)
- p53 signaling pathway (7)
- Cardiac muscle contraction (6)
- Complement and coagulation cascades (6)
- Lysosome (6)
- Oxidative phosphorylation (6)
- Type II diabetes mellitus (6)
- Arachidonic acid metabolism (5)
- Endometrial cancer (5)
- Glioma (5)
- Linoleic acid metabolism (5)
- Primary immunodeficiency (5)
- Renal cell carcinoma (5)
- Systemic lupus erythematosus (5)
- Vibrio cholerae infection (5)
- Viral myocarditis (5)
- Allograft rejection (4)
- Antigen processing and presentation (4)
- Autoimmune thyroid disease (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- Graft-versus-host disease (4)
- Non-small cell lung cancer (4)
- Riboflavin metabolism (4)
- Small cell lung cancer (4)
- Steroid biosynthesis (4)
- T cell receptor signaling pathway (4)
- Type I diabetes mellitus (4)
- Tyrosine metabolism (4)
- Androgen and estrogen metabolism (3)
- Asthma (3)
- Biosynthesis of unsaturated fatty acids (3)
- Chondroitin sulfate biosynthesis (3)
- Drug metabolism - other enzymes (3)
- Fatty acid metabolism (3)
- Glycerolipid metabolism (3)
- Glycerophospholipid metabolism (3)
- Porphyrin and chlorophyll metabolism (3)
- Prion diseases (3)
- RIG-I-like receptor signaling pathway (3)
- Starch and sucrose metabolism (3)
- Tryptophan metabolism (3)
- Acute myeloid leukemia (2)
- B cell receptor signaling pathway (2)
- Dorso-ventral axis formation (2)
- Ether lipid metabolism (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Glutathione metabolism (2)
- Heparan sulfate biosynthesis (2)
- Inositol phosphate metabolism (2)
- NOD-like receptor signaling pathway (2)
- Nicotinate and nicotinamide metabolism (2)
- Nitrogen metabolism (2)
- Pantothenate and CoA biosynthesis (2)
- Primary bile acid biosynthesis (2)
- Propanoate metabolism (2)
- Pyrimidine metabolism (2)
- Sphingolipid metabolism (2)
- Ubiquitin mediated proteolysis (2)
- Valine (2)
- leucine and isoleucine degradation (2)
- Arginine and proline metabolism (1)
- Ascorbate and aldarate metabolism (1)
- C21-Steroid hormone metabolism (1)
- Caffeine metabolism (1)
- Cell cycle (1)
- Cytosolic DNA-sensing pathway (1)
- Glycine (1)
- Glycosphingolipid biosynthesis - ganglio series (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (1)
- Histidine metabolism (1)
- Insulin signaling pathway (1)
- Keratan sulfate biosynthesis (1)
- O-Mannosyl glycan biosynthesis (1)
- Olfactory transduction (1)
- Pentose and glucuronate interconversions (1)
- Phenylalanine metabolism (1)
- Phosphatidylinositol signaling system (1)
- Terpenoid backbone biosynthesis (1)
- VEGF signaling pathway (1)
- serine and threonine metabolism (1)